Evidence map›Paper›PMID 35739528›Full record

ArticleBMC complementary medicine and therapies2022

Ellagic acid effects on testis, sex hormones, oxidative stress, and apoptosis in the relative sterility rat model following busulfan administration.

Amirabbas Rostami, Sina Vakili, Farhad Koohpeyma, Bahia Namavar Jahromi, Ziba Afshari Aghajari, Fatemeh Mahmoudikohani, Forough Saki, Marzieh Mahmoodi, Khojaste Rahimi Jaberi, Ahmad Movahedpour and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. International journal of endocrinology · 2026
    Article
  4. 5-ALA/FeFrontiers in cell and developmental biology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Amirabbas RostamiDepartment of Internal Medicine, Faculty of General Medicine, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
Sina VakiliInfertility Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Farhad KoohpeymaShiraz Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Bahia Namavar JahromiInfertility Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Ziba Afshari AghajariRadiation Oncology Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Fatemeh MahmoudikohaniDepartment of Midwifery, School of Nursing and Midwifery, Bam University of Medical Sciences, Bam, Iran.
Forough SakiShiraz Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Marzieh MahmoodiSchool of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Khojaste Rahimi JaberiShiraz nephro-urology research center, shiraz university of medical sciences, Shiraz, Iran.
Ahmad MovahedpourBehbahan Faculty of Medical Sciences, Behbahan, Iran.
Majid Jafari KhorchaniBiochemistry Department, Tarbiat Modares University, Tehran, Iran.
Saam NorooziDepartment of Biochemistry, Fasa University of Medical Sciences, Fasa, Iran. joursub17@gmail.com.ORCID https://orcid.org/0000-0003-2731-3587
Shiraz University of Medical Sciences · IRFasa University of Medical Sciences · IRIranshahr University · IRTarbiat Modares University · IRYerevan State Medical University · AM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBusulfan is an antineoplastic medication that is broadly utilized for cancer treatment. It affects the testicular function and leads to sterility. The present study aimed to evaluate the effects of ellagic acid on testicular tissue changes, sexual hormones, antioxidant defense system, and caspase-9 and Bcl2 gene expression in the busulfan-induced relative sterile rat model.

methodsThis is an interventional-experimental animal study that was performed on 65 Adult male rats; they were randomly divided into five groups including control (1 ml of 0.9% normal saline), ellagic acid (50 mg/kg); busulfan (10 mg/kg); and busulfan plus ellagic acid (10 mg/kg and 50 mg/kg). At the end of the experiment, blood samples were collected, and plasma levels of sex hormones, antioxidant system, apoptosis-related genes, and testis histology were assessed.

resultsBusulfan reduced the levels of serum testosterone, total antioxidant capacity, gene expression of Bcl2, testicular volume, seminiferous tubule, germinal epithelium, interstitial tissue volume, and the number of spermatogonia, spermatocyte, round spermatid, elongated spermatid, Sertoli cells and Leydig cells (p < 0.05). Busulfan administration resulted in a significant increase (p < 0.05) in the level of LH, FSH, malondialdehyde, and caspase 9. Busulfan + ellagic acid (50 mg/kg) showed higher serum levels of testosterone, gene expression of Bcl-2 and antioxidant markers, and lower LH, FSH levels, and gene expression of caspase 9 compared to the Busulfan-treated rats (p < 0.05). Stereological parameters were also ameliorated in the group treated with Busulfan+ 50 mg/kg ellagic acid (p < 0.05).

conclusionIn conclusion, the consumption of ellagic acid may have beneficial effects on the antioxidant defense system, sexual hormone abnormality, and testicular tissue damage induced by busulfan.

Indexed as

InfertilityTestisAnimalsAntioxidantsApoptosisBusulfanCaspase 9Ellagic AcidFollicle Stimulating HormoneMaleOxidative StressProto-Oncogene Proteins c-bcl-2RatsSpermatozoaTestosteroneAntioxidantsBusulfanCaspase 9Ellagic AcidFollicle Stimulating HormoneProto-Oncogene Proteins c-bcl-2TestosteroneEllagic acidRatSex hormonesSterilityTesticular tissue

Identifiers

PMID35739528
PMCPMC9229441
OpenAlexW4283325999

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.